Prosecution Insights
Last updated: August 13, 2026
Application No. 18/691,326

INTRA-CARDIAC DEVICE AND FIXING METHOD THEREFOR

Non-Final OA §102§103
Filed
Mar 12, 2024
Priority
Oct 05, 2021 — provisional 63/252,188 +3 more
Examiner
HULBERT, AMANDA K
Art Unit
3792
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Biotronik SE & Co. KG
OA Round
1 (Non-Final)
85%
Grant Probability
Favorable
1-2
OA Rounds
8m
Est. Remaining
89%
With Interview

Examiner Intelligence

Grants 85% — above average
85%
Career Allowance Rate
647 granted / 765 resolved
+14.6% vs TC avg
Minimal +4% lift
Without
With
+4.0%
Interview Lift
resolved cases with interview
Typical timeline
3y 1m
Avg Prosecution
28 currently pending
Career history
797
Total Applications
across all art units

Statute-Specific Performance

§101
4.0%
-36.0% vs TC avg
§103
42.1%
+2.1% vs TC avg
§102
24.9%
-15.1% vs TC avg
§112
23.1%
-16.9% vs TC avg
Black line = Tech Center average estimate • Based on career data from 765 resolved cases

Office Action

§102 §103
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Election/Restrictions Applicant’s election without traverse of Group 2, claims 4-10 in the reply filed on February 4, 2026 is acknowledged. Currently claims 1-10 are pending in this application with claims 1-3 withdrawn from consideration. Claim Rejections - 35 USC § 102 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. Claims 4-6 and 9-10 are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Bornzin (US 2013/0016740). Regarding claim 4, Bornzin discloses an intracardiac device comprising (e.g. as shown in Figures 3A and 4C) one electrode (e.g. electrode 318) and at least two tines attached at a distal end of the intra-cardiac device adjacent the electrode (e.g. fixation mechanisms 430, 431), wherein each of the at least two tines has a distal end in form of a hook with the furthest distal end section of the tine pointing inwards, is pivotable outwards around a bending point at its proximal end and/or bendable, wherein the at least two tines are further adapted to pivoted outwards and/or bent outwards when the at least two tines are pressed against the tissue of a patient's heart at an anchoring region, thereby the distal ends of the at least two tines penetrate into the tissue, and- to bunch a wall segment of the tissue and to pull this wall segment towards the electrode when the intra-cardiac device is moved a pre-defined distance back from the anchoring region (e.g. distal region 435 of the fixation mechanism as shown in Figure 4C and [0098]). Examiner notes that the claims are apparatus claims and as such need only be capable of performing the functional use limitations of penetrating the tissue and bunching a wall segment of the tissue. Regarding claim 5, Bornzin additionally discloses wherein at the distal end of the intra-cardiac device the electrode is located at a central position and the proximal ends of the at least two tines are located at a circumference around the electrode (e.g. as shown in Figure 4C). Regarding claim 6, Bornzin additionally discloses wherein the length of the at least two tines is in the range of 2 mm to 10 mm and/or the length of the electrode is equal to or less than 5 mm, wherein the each length is determined into the direction of a longitudinal axis of the intracardiac device (e.g. the device as shown in Figure 4C is shown to penetrate the wall between the atrium and the ventricle which will necessarily be between 2 and 10 mm). Regarding claim 8, Bornzin additionally discloses wherein the distal end section of the at least two tines is curved such that its furthest end points towards the electrode (e.g. as shown in Figure 4C). Regarding claim 9, Bornzin additionally discloses wherein the distal section or more of the at least two tines comprise one or more barbs (e.g. hooks as shown in Figure 4C). Regarding claim 10, Bornzin additionally discloses wherein the tines comprise a proximal section and a distal section, whereby the proximal section of the is straight and parallel to the longitudinal axis of the intra-cardiac device and the distal section is formed as a hook (e.g. straight and hook sections as shown in Figure 4C). Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. Claim 7 is rejected under 35 U.S.C. 103 as being unpatentable over Bornzin. Regarding claim 7, Bornzin discloses the claimed invention but does not disclose expressly wherein the diameter of the distal end of the at least two tines is in the range of 1 mm to3 mm. It would have been an obvious matter of design choice to a person of ordinary skill in the art to modify the tines as taught by Bornzin with the desired tine diameters, because Applicant has not disclosed that such a diameter provides an advantage, is used for a particular purpose, or solves a stated problem. One of ordinary skill in the art, furthermore, would have expected Applicant’s invention to perform equally well with the tines as taught by Bornzin, because it provides a reliable fixation mechanism and since it appears to be an arbitrary design consideration which fails to patentably distinguish over the prior art. Therefore, it would have been an obvious matter of design choice to modify Bornzin to obtain the invention as specified in the claims. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to Amanda K Hulbert whose telephone number is (571)270-1912. The examiner can normally be reached Monday - Friday 9:00-5:00. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Unsu Jung can be reached at 571-272-8506. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /Amanda K Hulbert/Primary Examiner, Art Unit 3792
Read full office action

Prosecution Timeline

Mar 12, 2024
Application Filed
May 18, 2026
Non-Final Rejection mailed — §102, §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12691280
CURRENT STEERING TO ACHIEVE SPATIAL SELECTIVITY FOR HIS BUNDLE PACING
4y 2m to grant Granted Jul 28, 2026
Patent 12691289
IMPLANTABLE MEDICAL DEVICE, IMPLANT COMMUNICATION SYSTEM AND METHOD FOR TRANSFERRING DATA
2y 8m to grant Granted Jul 28, 2026
Patent 12691290
IMPLANTABLE MEDICAL DEVICE, IMPLANT COMMUNICATION SYSTEM AND COMMUNICATION METHOD
2y 8m to grant Granted Jul 28, 2026
Patent 12685870
APPARATUSES AND METHODS FOR TIMING-BASED POWER LEVEL CONTROL
2y 8m to grant Granted Jul 21, 2026
Patent 12678629
5G Implant
2y 11m to grant Granted Jul 14, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
85%
Grant Probability
89%
With Interview (+4.0%)
3y 1m (~8m remaining)
Median Time to Grant
Low
PTA Risk
Based on 765 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month